Showing results (81-90 of 122) with videos related to

Sort By:
Pageof 13
Metabolic Brain Disease|December 18, 2022
Confusion assessment method accurately screens for hepatic encephalopathy and predicts short-term mortality in hospitalized patients with cirrhosisArchita P Desai, Devika Gandhi, Chenjia Xu, et al.
Journal of Pain and Symptom Management|February 24, 2022
Palliative Care, Patient-Reported Measures, and Outcomes in Hospitalized Patients With CirrhosisEric S Orman, Andrew Yousef, Chenjia Xu, et al.
Clinical Pharmacology and Therapeutics|July 26, 2026
Beyond Hy's Law: Importance of Markedly Elevated Aminotransferases without HyperbilirubinemiaNaga Chalasani, Ismael Alvarez-Alvarez, Paul H Hayashi, et al.
The American Journal of Gastroenterology|December 24, 2010
Hepatic and extrahepatic cancer in cirrhosis: a longitudinal cohort studyKenneth Berman, Sweta Tandra, Raj Vuppalanchi, et al.
Clinical and Translational Gastroenterology|April 7, 2020
Significant Medical Comorbidities Are Associated With Lower Causality Scores in Patients Presenting With Suspected Drug-Induced Liver InjuryMarwan Ghabril, Jiezhun Gu, Lindsay Yoder, et al.
Alimentary Pharmacology & Therapeutics|December 22, 2022
Potential benefit and lack of serious risk from corticosteroids in drug-induced liver injury: An international, multicentre, propensity score-matched analysisHao Niu, Jiayi Ma, Inmaculada Medina-Caliz, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|April 7, 2022
Neighborhood poverty is associated with failure to be waitlisted and death during liver transplantation evaluationKawthar A Mohamed, Marwan Ghabril, Archita Desai, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 22, 2013
Liver injury from tumor necrosis factor-α antagonists: analysis of thirty-four casesMarwan Ghabril, Herbert L Bonkovsky, Clarissa Kum, et al.
Hepatology (Baltimore, Md.)|May 24, 2023
PROMIS Profile-29 is a valid instrument with distinct advantages over legacy instruments for measuring the quality of life in chronic liver diseaseArchita P Desai, Abhishek Madathanapalli, Qing Tang, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 4, 2018
Sclerosing Cholangitis-Like Changes on Magnetic Resonance Cholangiography in Patients With Drug Induced Liver InjuryJawad Ahmad, Simona Rossi, Shuchi K Rodgers, et al.
Pageof 13